Regeneron eye drug Eylea wins U.S. approval for new use
2012/09/21
By ModernMedecineSubscribe
Recent Posts
- FDA approves Trulign toric accommodating IOL
- Minimally invasive vitrectomy effective for floaters
- SAFE strategy to eliminate blinding trachoma by year 2020
- Intracameral cefuroxime non-toxic for the macula with proper dosing following cataract surgery
- Long-term series shows good cataract surgery results in patients previously implanted with iris-claw phakic IOLs
Tags
AAO
AMD
anti-VEGF
artificial retina
avastin
Clinical Case
Commentary
Conference Coverage
contact lens
contact lenses
corticosteroid
degeneration
diabetes
Diabetes & Endocrinology
diabetic macular edema
diabetic retinopathy
DME
dry eye
endophthalmitis
Expert Column
eye-tracking
Eye Health / Blindness
Family Medicine/Primary Care
femtosecond
gene therapy
IOL
Journal Article
lasik
lucentis
macular edema
Neurology / Neuroscience
News
News Alert
OCT
Ophthalmology
poppers
presbyopia
retinal detachment
retinal vein occlusion
retinitis pigmentosa
stem cells
surgery
trauma
Treatments
Viewpoint
Archives
Sources
- Advanced Ocular Care – Issues
- Advanced Ocular Care – News
- Am J Ophthal – n Press
- Am J Ophthalmol – current
- Business Wire
- Cataract & Refractive Surgery Today – Issues
- Cataract & Refractive Surgery Today – News
- Clinical Trials Updates
- EyeDocNews Blog
- Eyewire Today
- Healio
- IOVS/SciVee
- Irv Arons' Journal
- Medgadget
- Medical News Today
- MedicineWorld
- MedPage Today
- Medscape
- Medscape Ophthalmology Podcast
- MedscapeCME Ophthalmology Podcast
- ModernMedicine – Ophthalmology
- NeLM – Ophthalmology
- NHS Evidence
- Ophthalmology
- Ophthalmology – in press
- Ophthalmology Update
- OphthalmologyWeb
- OphthalmologyWeb Videos
- OphthoBook (videos)
- Progress in Retinal and Eye Research
- RetinaEyeDoctor.com
- Root Atlas
- ScienceDaily
- The Medical News